Pharmacy Industry Leadership: An Overview of USP - February 22, 2014 10:30 - 11:30 AM
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
February 22, 2014 10:30 – 11:30 AM Pharmacy Industry Leadership: An Overview of USP Jeanne Sun, Pharm.D. Associate Scientific Liaison Healthcare Quality Standards
The first Pharmacopeia (1820) The first Pharmacopoeia of the United States contained 217 of the “most fully established and best understood” medicines in the U.S. It was published “by the authority of the medical societies and colleges.” 3
About USP Scientific non-profit organization that sets standards for the identity, strength, quality, and purity of medicines, food ingredients, and dietary supplements USP Headquarters Rockville, MD USP’s Mission: To improve global health through public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods. 4
About USP What We Do Today – Establish and disseminate public written standards for the quality, purity, identity, strength, and labeling of medicines – Provide recommendations to practitioners on the safe use of medicines – Work with international health agencies to improve the quality of medicines worldwide – Educate practitioners, producers and others seeking information on quality and USP standards 5
USP Standards The United States Pharmacopeia National Formulary (USP–NF) Food Chemicals Codex (FCC) USP Dietary Supplements Compendium (DSC) USP on Compounding USP Medicines Compendium (MC) Herbal Medicines Compendium (HMC) Reference Standards Other Resources – Pharmacopeial Forum (PF) – FCC Forum (FCCF) – USP Dictionary – Chromatographic Columns 7
Legal Recognition Around the World USP standards are used in more than 140 countries around the world. Medicines Food Ingredients – Exportation of medicines to The Food Chemicals Codex (FCC) the U.S. should abide by U.S. compendium are recognized in: law and U.S. FDA Canada – food additive must regulations, which specify comply with specifications in USP–NF standards. FCC Australia and New Zealand – primary source of identity and purity specifications for substances added to food Brazil – FCC standards are recommended, along with other standards. Israel – food additive must comply with FCC or iJECFA. 8
Legal Recognition in the US 1848 Drug Import Act 1994 Dietary Supplement recognized USP standards to Health Education Act stop the dumping of drugs by recognize USP standards for Europeans dietary supplements 1906 Pure Food and Drugs Act enforced USP and NF standards for strength, quality, and purity 1938 Food, Drug and Cosmetic Act recognized USP & NF standards for strength, quality, purity, packaging, and labeling 9 9
Legal Recognition in the US 1997FDA Modernization Act 2013Drug Quality and Sec. 503A stated that Security Act recognize USP compounding must comply with monographs for bulk drug USP-NF standards and chapter substances and USP chapters on pharmacy compounding on pharmacy compounding 2003Medicare Modernization Act requested USP to develop and revise the Model Guidelines for Medicare Formularies 2010Affordable Care Act recognizes USP Model Guidelines to assess coverage of Essential Health Benefits 10 10
USP Healthcare Quality Standards Expert Committees (2010-2015) – Nomenclature, Safety and Labeling Expert Committee • Scientific Liaison: Andrzej Wilk, Ph.D. • Scientific Liaison: Donna Bohannon, R.Ph. – Compounding Pharmacy Expert Committee • Scientific Liaison: Rick Schnatz, Pharm.D. • Scientific Liaison: Jeanne Sun, Pharm.D – Therapeutic Information and Formulary Support • Scientific Liaison: Jami Earnest, Pharm.D Expert Panels and Advisory Groups – Prescription Container Labeling – Compounding with Hazardous Drugs – Pharmaceutical Compounding – Sterile Preparations 11
Nomenclature, Safety and Labeling Expert Committee
Monograph Titles 1. Substance monograph Amlodipine Besylate 2. Product monograph Amlodipine Besylate Tablets 3. Compounded Preparation monograph Amlodipine Oral Suspension 13
USP Dictionary Entry Components – U.S. Adopted Name (USAN) – Pronunciation Guide – Molecular formula and weight – Chemical Name – CAS registry number(s) – Other nonproprietary names – Pharmacologic and/or therapeutic activity – Brand name(s) – Name(s) of manufacturer – Graphic formula 14
Reference Tables Container for Dispensing Capsules and Tablets – Relevant tight (T) – Well-closed (W) – Light-resistant (LR) Solubility Atomic weights 15
Prescription Container Labeling Purpose – To develop standards for prescription container labels as they are the patient’s best source. The prescription container label must be able to fulfill the professional obligations of the healthcare provider to give the patient all the information needed to understand how to safely use the medication Official May 2013 Take: 2 tablets in the morning 2 tablets in the evening 16
Physical Environments that Promote Safe Medication Use Purpose – To describe optimal physical environment standards to promote accurate medication use and improve performance since the work environment has been identified as one of the most commonly reported factors contributing to medication errors Physical Environments addressed: – Illumination – Sound and Noise – Interruptions and Distractions – Physical Design and Organization of Workspace 17
Safety Focused Labeling Initiatives Ferrules and Cap Overseals Strength and Total Volume Prescription Container Labeling 18
USP Pictograms Standardized graphic images that help convey medication instructions, precautions, and/or warnings to patients and consumers. – Deliver important information to patients with a lower level reading ability and patients for whom English is a second language. – Reinforce printed or oral instructions. Currently USP offers 81 pictograms – Tested for comprehension Available for download (free of charge) – http://www.usp.org/usp-healthcare- professionals/related-topics-resources/ usp-pictograms 19
Compounding Expert Committee
Compounding Definition – The preparation of a drug in accordance with a licensed practitioner’s prescription or medication order based on the triad relationship. Why compound? Viable Alternatives? – Pediatric patients – Crushing Tablets – Geriatric patients – Splitting Tablets – Animal patients – IV Solutions – Non-standard doses – Allergen-free medication – HRT – Sports Injuries – Pain management – Drug Shortages – Discontinuation by manufacturer 21 21
Compounding General Chapters Pharmaceutical Compounding – Nonsterile Preparations Pharmaceutical Compounding-Sterile Preparations Quality Assurance in Pharmaceutical Compounding Pharmaceutical Calculations in Prescription Compounding Prescription Balances & Volumetric Apparatus 22
Hazardous Drugs – Handling in Healthcare Settings Purpose – To clearly identify the requirements for handling of hazardous drugs to protect the patient, healthcare personnel, and environment. – Processes intended to provide containment of HDs to as low a limit as reasonably achievable – Harmonization of OSHA , NIOSH, ASHP, and ONS guidelines – Addresses receipt, storage, mixing, preparing, compounding (sterile and nonsterile), dispensing, and administration of hazardous drugs 23
Compounding for Investigational Studies Purpose: – To guide compounding practitioners in the extemporaneous compounding of drugs used in investigational studies. – Should be in compliance with all the appropriate USP general chapters and USP–NF standards pertaining to compounding – Chapter provides additional standards for compounding for investigational preclinical and early phase I investigations New chapter proposal for PF39(5) Sept-Oct 2013 – Targeted publication in USP37-NF32 (2nd Supplement) 24
Compounded Preparation Monographs COMPOUND PILLS OF JALAP Take of Jalap in powder; Rhubarb in powder; Castile soap, each one ounce. Submuriate of mercury six drachms and two scruples. Tartarized antimony, twenty eight grains. With water form a mass and divide into four hundred pills.
Components of a Compounded Preparation Monograph Title Definition - Lists the range of labeled amount of active ingredient Formula - Ingredients and quantities Compounding Procedures Stability-indicating Assay pH Packaging and Storage Labeling Beyond-use dates - Stability studies - Chapters or 26
Clinical Case S: Malnourished white male At 3 months, developed “cradle cap” O: At 6 months, weighed 4 pounds Widespread weeping cutaneous lesions covering body Seizures and Impaired digestion A: P: Acrodermatitis enteropathica is an autosomal recessive metabolic disorder affecting the uptake of zinc, characterized by periorificial and acral dermatitis, alopecia, and diarrhea. Fatal if untreated. 27
Clinical Case Zinc Sulfate 44 mg/mL 123 Pharmacy Road Rockville, MD Solution (123)555-‐0123 Zinc sulfate, granular 4.4 g Name: Baby Johnson Age: (heptahydrate) 6 months Date: June 26, 2013 Cherry syrup, NF 45 mL Purified Water, NF, a 100 mL Zinc Sulfate 44 mg/mL sufficient quantity to Oral Solution make Sig: 3.5 mL/day of zinc Note: Elemental zinc 1 mg is equivalent (equiv 154 mg/day Zinc) to zinc sulfate 2.47 mg or zinc sulfate Disp: 50 mL heptahydrate 4.4 mg. ReLills: 3 Signature: Dr. Smith
Therapeutic Information and Formulary Support Expert Committee 29
Medicare Modernization Act (MMA) 2003 Section 1860D-4(b)(3)(C) defines role of USP: “(ii) MODEL GUIDELINES The [HHS] Secretary shall request the United States Pharmacopeia to develop, in consultation with pharmaceutical benefit managers and other interested parties, a list of categories and classes that may be used by prescription drug plans under this paragraph and to revise such classification from time to time to reflect changes in therapeutic uses of covered part D drugs and the additions of new covered part D drugs.” Section 1860D-11(e)(2)(D) creates “safe harbor”: “(ii) USE OF CATEGORIES AND CLASSES IN FORMULARIES. The Secretary may not find that the design of categories and classes within a formulary violates clause (i) if such categories and classes are consistent with guidelines (if any) for such categories and classes established by the United States Pharmacopeia.”
USP Medicare Model Guidelines Development USP MMG v1.0 (2005) involved: – Expert Committee – Environmental scan – Public advisory meetings – Public comment process Revision from “time to time” – USP MMG v2.0 (2006) – USP MMG v3.0 (2007) – USP MMG v4.0 (2008) – USP MMG v5.0 (2011) – USP MMG v6.0 (2014) Arch Intern Med 2006; 145:448-453. 31
USP Medicare Model Guidelines USP MMG are…. USP MMG are not…. √Structural model of categories ≠ Formulary or list of essential and classes medications √Part of a CMS Part D formulary ≠ Mandated in their entirety (plans check that requires 2 drugs from can adjust their formulary each category/class category/class names) √Therapeutically driven by FDA ≠ Drug classification based solely indications xxxxxxxxxx upon pharmacology/chemistry √Specific to Part D drugs and ≠ Inclusive of all medications or Medicare Beneficiaries patients 32
ACA Essential Health Benefits ACA requires health plans to cover “Essential Health Benefits” (EHB) within 10 benefit categories, including prescription drugs HHS Final Rule (2/25/13) cites USP Medicare Model Guidelines – “…in order to comply with the requirement to cover EHB, a plan would cover at least the greater of: (1) One drug in every USP category and class; or (2) the same number of drugs in each category and class as the EHB-benchmark plan. “ For 2014-2015, HHS makes use of USP Medicare Model Guidelines v5.0 33
Looking ahead…. Expert Panels to address therapeutic information needs expressed by USP Convention membership • Information and decision support for drug shortages • Biologic products • Precision medicine Data collected by the University of Utah Drug Information Service. Data for 2012 are through Dec 31, 2012. 34
Opportunities at USP 35
Council of Experts & Expert Committees Council of Experts – oversees USP's scientific and standards-setting decisions Expert Committees – responsible for developing and revising USP standards that comprise its seven compendia Expert Panel – formed to provide additional expertise on a particular compendial topic, thereby supplementing Expert Committee expertise Call for Candidate for 2015-2020 Convention Cycle – Deadline for Application: Jan 1, 2015 – http://uspgo.to/call-candidates. 36
Summer Internship Program Offers students of chemistry, pharmaceutical sciences, and related science disciplines, the fulfilling opportunity to work on a defined project that expands and enhances USP's core strategic initiatives focusing on the following areas: – Healthcare Quality Standards – Reference Standards Laboratory—Quality of Manufactured Medicines – Global Health Impact Program—Quality of Medicines – Excipients Duration: 12 weeks, 37.5 hour work week Location: U.S. Pharmacopeia Headquarters (Rockville, MD) Dates: May 26, 2014 – August 15, 2014 More information can be found at http://www.usp.org/about-usp/careers/internship-fellowship-programs 37
Global Fellowship Awards Program Promotes research in areas relating to standards for medicines, foods, and dietary supplements and their use USP Global Fellowship Awards of up to $50,000 are presented to the students whose proposed research directly address a specific USP scientific or research need. Eligibility – Have been accepted for full-time study in a Ph.D. or Pharm.D. program – Have been accepted to a Fellowship Program; – Or have been awarded a postdoctoral research (non-faculty) appointment. Application Deadline: May 2, 2014 More information can be found at http://www.usp.org/about-usp/careers/internship-fellowship-programs 38
Career Opportunities Being a part of USP means belonging to a diverse culture made up of more than 800 talented professionals working together at five international locations. We share our expertise in science, IT, human resources, quality assurance, communications, administrative management, and more...all to support an overall mission dedicated to making a difference by providing standards and programs that help improve the quality of medicines, dietary supplements, and foods worldwide. Current openings can be found at: https://uspcareers.silkroad.com/ uspext/EmploymentListings/ EmploymentListingsUSP.html 39
My pathway to USP 40
You can also read